acetylcysteine has been researched along with ADDH in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banaschewski, T; Dijkhuizen, RM; Dittmann, RW; Durston, S; Glennon, JC; Häge, A; K Buitelaar, J; Mechler, K; Murphy, D; Schweinfurth, N; Tactics Consortium, T; Williams, S | 1 |
Alvarenga, PG; Bloch, MH; Jakubovski, E; Landeros-Weisenberger, A; Leckman, JF; Mulqueen, JM; Panza, KE; Yaffa, A | 1 |
Dawood, M; Faraone, SV; Francis, L; Garcia, RJ; Lai, ZW; Perl, A | 1 |
1 review(s) available for acetylcysteine and ADDH
Article | Year |
---|---|
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature.
Topics: Acetylcysteine; Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Child; Corpus Striatum; Excitatory Amino Acid Agents; Glutamic Acid; Humans; Memantine; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Receptors, Glutamate; Risk Assessment; Treatment Outcome | 2018 |
2 trial(s) available for acetylcysteine and ADDH
Article | Year |
---|---|
N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Topics: Acetylcysteine; Adolescent; Anxiety; Attention Deficit Disorder with Hyperactivity; Child; Depression; Double-Blind Method; Female; Free Radical Scavengers; Humans; Linear Models; Male; Obsessive-Compulsive Disorder; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome | 2016 |
Attention deficit and hyperactivity disorder scores are elevated and respond to N-acetylcysteine treatment in patients with systemic lupus erythematosus.
Topics: Acetylcysteine; Adult; Aged; Attention Deficit Disorder with Hyperactivity; Early Diagnosis; Female; Free Radical Scavengers; Health Status; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Neuropsychological Tests; Self Report; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2013 |